Pt had been on azithromycin and prednisone taper for PNA and COPD exacerbation.
GI, surgery and IR were consulted.
He remained HD stable through MICU stay and is transferred to the floor with planned colonscopy for Monday.
Past Medical History: PUD DM2 CHF A. flutter AAA s/p endovascular repair Heart Block s/p PPM squamous cell ca n Bladder malignancies   Social History: widowed, retired (from restaurant industry), former smoker, no ETOH  Family History: non-contributory  Physical Exam: PE: Vitals: T 98.1, BP 135/63, HR 60, RR 18, O2 sat 100% 3L NC Gen: alert and oriented, speech spontaneous and fluent, poor historian HEENT: NC/AT, PERRLA, EOMI, Dry MM CV: RRR, nl S1/s2, no M/R/G, flat JVP Resp: clear anteriorly, decreased BS at bases w/ dullness to percussion Abd: obese, mildly distended, NABS, non-tender, no rebound/guarding Ext: 1+ edema LE b/l Skin: scattered hypersegmented lesions on face and neck Neuro: moving all extremities, non-focal  Pertinent Results: [**2110-3-5**] 09:00AM   WBC-18.1* RBC-2.25* HGB-7.7* HCT-23.3* MCV-104* MCH-34.1* MCHC-32.9 RDW-14.8 [**2110-3-5**] 09:00AM   NEUTS-76.9* LYMPHS-17.7* MONOS-4.5 EOS-0.7 BASOS-0.2 [**2110-3-5**] 09:00AM   PLT COUNT-157 [**2110-3-5**] 09:00AM   CK(CPK)-55 [**2110-3-5**] 09:00AM   cTropnT-0.12* [**2110-3-5**] 09:00AM   GLUCOSE-91 UREA N-60* CREAT-2.7* SODIUM-142 POTASSIUM-5.0 CHLORIDE-107 TOTAL CO2-27 ANION GAP-13 [**2110-3-5**] 04:24PM   CK(CPK)-45 [**2110-3-5**] 04:24PM   cTropnT-0.10* [**2110-3-5**] 06:50PM   PT-15.5* PTT-38.1* INR(PT)-1.4* [**2110-3-5**] 06:50PM   WBC-14.9* RBC-3.30*# HGB-10.3*# HCT-30.2*# MCV-92# MCH-31.2 MCHC-34.0 RDW-15.9* [**2110-3-5**] 06:50PM   NEUTS-86.3* BANDS-0 LYMPHS-7.3* MONOS-6.1 EOS-0.3 BASOS-0 [**2110-3-5**] 06:57PM   HGB-10.4* calcHCT-31 [**2110-3-5**] 11:40PM   PT-13.0 PTT-28.5 INR(PT)-1.1 [**2110-3-5**] 11:40PM   PLT COUNT-41* [**2110-3-5**] 11:40PM   WBC-19.1* RBC-5.31# HGB-16.5# HCT-45.9# MCV-87 MCH-31.1 MCHC-36.0* RDW-16.2* [**2110-3-5**] 11:40PM   NEUTS-80.7* LYMPHS-12.9* MONOS-5.8 EOS-0.2 BASOS-0.4 [**2110-3-5**] 11:40PM   CALCIUM-6.6* PHOSPHATE-5.5* MAGNESIUM-2.1 [**2110-3-5**] 11:40PM   CK-MB-NotDone cTropnT-0.08* [**2110-3-5**] 11:40PM   CK(CPK)-65 [**2110-3-5**] 11:40PM   GLUCOSE-271* UREA N-56* CREAT-2.3* SODIUM-140 POTASSIUM-5.4* CHLORIDE-110* TOTAL CO2-21* ANION GAP-14 .
Nasogastric tube terminates in the stomach.
Patient is status post endograft repair of an infrarenal abdominal aortic aneurysm with graft material extending from below the takeoff of the renal arteries into both common iliac arteries.
CT OF THE PELVIS WITHOUT IV CONTRAST: There is a Foley catheter within the decompressed urinary bladder.
There are a few scattered colonic diverticula but no evidence of acute diverticulitis.
Status post endograft repair of large infrarenal abdominal aortic aneurysm which measures 5.8 cm maximal diameter.
Consider vascular surgery eval re:aorto-enteric herald bleed +/- capsule endoscopy.
[**2110-3-10**] Path Procedure date     Tissue received     Report Date    Diagnosed by [**2110-3-10**] [**2110-3-10**] [**2110-3-12**] DR. [**Last Name (STitle) **].
RIGHT ATRIUM/INTERATRIAL SEPTUM: A catheter or pacing wire is seen in the RA and extending into the RV.
[**2110-3-15**] ABD US FINDINGS: Patient is status post endograft repair of an abdominal aortic aneurysm, and although evaluation is limited, there appears to be wall- to- wall flow within the aortic lumen without flow noted in the excluded thrombosed aneurysm.
The left kidney measures 9.9 cm.
IMPRESSION: Wall-to-wall flow within the aorta status post aneurysm repair with slightly smaller size of aneurysmal sac compared to prior CT torso.
Following the administration of oral thin barium overhead and fluoroscopic spot images of the small bowel were obtained.
GI, general surgery and IR were consulted.
Surgery felt no indication for acute surgical intervention as the patient stabalized with transfusion.
Unable to localize well enough for possible surgical intervention.
His HCT has remained stable, received transfsion on [**3-14**] and [**3-16**] for slowly trending down HCT.
He will continue on pantoprazole.
His asprin was discontinued due to his risk of bleed with low platelet counts.
His aspirin should be discontinued due to his history of thrombocytopenia and GI bleed.
He was restarted on his home dose lasix 20mg daily once HD stabilized.
He should continue on losartan 25mg daily.
# DM - The patient was maintained on SSI and NPH.
He should continue on NPH with titration of dose as needed.
# COPD - The patient was recently treated for exacerbation and PNA.
His prednisone was discontinued as it was felt it may contribute to GI bleeding.
He was briefly intubated in the MICU for airway protection but quickly extubated and weaned off O2.
He was continued on nebulizers as needed.
# Hyperlipidemia - continue statin .
# Code - Full code - discussed with patient on [**2110-3-14**]  Medications on Admission: insulin NPH 32 qAM/5 qPM SSI ambien 5mg prn ambien cr 6.25mg qhs tylenol 1000mg prn mvi asa 325mg qdaily colace 100mg qdaily lidodern 5% patch qdaily douneb qdaily mucinex 600mg [**Hospital1 **] flonase 50mcg 2 sprays [**Hospital1 **] bismuth subsalicylate 262mg prn simvastatin qdaily amlodipine 2.5mg qdaily omeprazole simethacone q cap qdaily lactulose 20g qdaily cetylpuridinium lozenges losartan 25mg qdaily metacmucil lasix 20mg qdaily calcium 500mg qdaily prednisone taper (currently 10mg) recently completed azithromycin course   Discharge Medications: 1.
Amlodipine 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed.
Losartan 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Aluminum-Magnesium Hydroxide 225-200 mg/5 mL Suspension Sig: 15-30 MLs PO QID (4 times a day) as needed.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Insulin NPH Human Recomb 100 unit/mL Suspension Sig: Twenty Seven (27)  Subcutaneous QAM.
Insulin Lispro 100 unit/mL Cartridge Sig: Per sliding scale Subcutaneous four times a day: Use per sliding scale.
DuoNeb 0.5-2.5 mg/3 mL Solution for Nebulization Sig: One (1)  Inhalation every 4-6 hours as needed for shortness of breath or wheezing.
Flonase 50 mcg/Actuation Spray, Suspension Sig: Two (2) Nasal twice a day.
Calcium 500 mg Tablet Sig: One (1) Tablet PO once a day.
Simvastatin 10 mg Tablet Sig: One (1) Tablet PO once a day.
Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day) as needed for PRN constipation.
Discharge Instructions: You were admitted with bleeding from your gastrointestinal tract and required multiple blood transfusion because of your large amount of bleeding.
Your medication aspirin has been stopped as it may increase your risk of bleeding.
Your medication NPH has been decreased to 27Units in the morning and no NPH in the evening as you have had low night time blood sugars.
Please continue to monitor your blood sugar and follow up with Dr. [**First Name (STitle) **] for further management of your diabetes.
Please continue to take the remainder of your medications as directed.
